Basic information Source Reactivity Background References Safety Supplier Related

USP9X antibody

Basic information Source Reactivity Background References Safety Supplier Related

USP9X antibody Basic information

Product Name:
USP9X antibody
Synonyms:
  • USP9X antibody
MW:
0
Mol File:
Mol File
More
Less

USP9X antibody Usage And Synthesis

Source

Rabbit

Reactivity

Human;Mouse;Rat;Monkey;Dog

Background

Protein ubiquitination and deubiquitination are reversible processes catalyzed by ubiquitinating enzymes and deubiquitinating enzymes respectively. DUBs are categorized into five subfamilies-USP, UCH, OTU, MJD, and JAMM. Ubiquitin-specific protease 9, X-linked possesses a well-conserved catalytic domain with cysteine peptidase activity, which allows for cleavage of ubiquitin and polyubiquitin conjugates. USP9X is the mammalian homolog of the Drosophila fat-facets gene, which is essential for normal eye development and viability of the early fly embryo. While USP9X expression is also critical for normal mammalian development, many of its substrates are only beginning to be elucidated. There is mounting evidence that USP9X functions in the formation of epithelial cell-cell contacts through deubiquitination-dependent stabilization of molecules involved in maintaining the integrity of both adherens and tight junctions. Indeed, USP9X has been found to associate with AF-6, the β-catenin-E-cadherin complex, and EFA6. Research studies have also demonstrated that USP9X is an integral component of the TGF-β/BMP signaling cascade by opposing TRIM33-mediated monoubiquitination of SMAD4. USP9X is overexpressed in a variety of human cancers and contributes to enhanced cell survival, in part, through its ability to deubiquitinate and stabilize the Mcl-1 oncoprotein. There is some evidence, however, that suggests the role of USP9X in tumorigenesis is context dependent. Research studies have implicated USP9X in a tumor suppressor role during the early stages of pancreatic ductal adenocarcinoma and in an oncogenic role during advanced stages of PDAC.

References

[1] Nijman, S.M. et al. (2005) Cell 123, 773-86.
[2] Nalepa, G. et al. (2006) Nat Rev Drug Discov 5, 596-613.
[3] Huang, Y. et al. (1995) Science 270, 1828-31.
[4] Huang, Y. and Fischer-Vize, J.A. (1996) Development 122, 3207-16.
[5] Pantaleon, M. et al. (2001) Mech Dev 109, 151-60.
[6] Noma, T. et al. (2002) Mech Dev 119 Suppl 1, S91-5.
[7] Xu, J. et al. (2005) J Neurosci Res 80, 47-55.
[8] Taya, S. et al. (1998) J Cell Biol 142, 1053-62.
[9] Taya, S. et al. (1999) Genes Cells 4, 757-67.
[10] Murray, R.Z. et al. (2004) Mol Biol Cell 15, 1591-9.

USP9X antibodySupplier

Novus Biologicals
Tel
400821347
Email
orders@novusbio.com
CUSABIO TECHNOLOGY LLC
Tel
027-87196173
Email
cusabio@163.com
Hubei Serenity BioSolutions Co., Ltd.
Tel
027-19371278702 18008634902
Email
19384116026@163.com
GeneTex, Inc.
Tel
0755-26755892 1-949-553-1900
Email
international@genetex.com
Enzo Biochem Inc
Tel
Enzo Biochem Inc. 13797054060
Email
Enzoname@qq.com